U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H35N9O8S
Molecular Weight 597.645
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ATN-161

SMILES

CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O

InChI

InChIKey=MMHDBUJXLOFTLC-WOYTXXSLSA-N
InChI=1S/C23H35N9O8S/c1-11(34)32-4-2-3-17(32)23(40)29-14(5-12-7-26-10-27-12)20(37)30-15(8-33)21(38)31-16(9-41)22(39)28-13(19(25)36)6-18(24)35/h7,10,13-17,33,41H,2-6,8-9H2,1H3,(H2,24,35)(H2,25,36)(H,26,27)(H,28,39)(H,29,40)(H,30,37)(H,31,38)/t13-,14-,15-,16-,17-/m0/s1

HIDE SMILES / InChI

Molecular Formula C23H35N9O8S
Molecular Weight 597.645
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.69 µM [Kd]
1.0 µM [Kd]
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:29:17 GMT 2023
Edited
by admin
on Fri Dec 15 16:29:17 GMT 2023
Record UNII
XW0H5LE42K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ATN-161
Code English
(2S)-2-(((2R)-2-(((2S)-2-(((2S)-2-(((2S)-1-ACETYLPYRROLIDINE-2-CARBONYL)AMINO)-3-(1H-IMIDAZOL-4-YL)PROPANOYL)AMINO)-3-HYDROXY-PROPANOYL)AMINO)-3-SULFANYL-PROPANOYL)AMINO)BUTANEDIAMIDE
Systematic Name English
ATN 161
Code English
AC-PHSCN-NH2
Common Name English
L-ASPARTAMIDE, 1-ACETYL-L-PROLYL-L-HISTIDYL-L-SERYL-L-CYSTEINYL-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C2050
Created by admin on Fri Dec 15 16:29:17 GMT 2023 , Edited by admin on Fri Dec 15 16:29:17 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID60180877
Created by admin on Fri Dec 15 16:29:17 GMT 2023 , Edited by admin on Fri Dec 15 16:29:17 GMT 2023
PRIMARY
NCI_THESAURUS
C52185
Created by admin on Fri Dec 15 16:29:17 GMT 2023 , Edited by admin on Fri Dec 15 16:29:17 GMT 2023
PRIMARY NCIT
PUBCHEM
9960285
Created by admin on Fri Dec 15 16:29:17 GMT 2023 , Edited by admin on Fri Dec 15 16:29:17 GMT 2023
PRIMARY
DRUG BANK
DB05491
Created by admin on Fri Dec 15 16:29:17 GMT 2023 , Edited by admin on Fri Dec 15 16:29:17 GMT 2023
PRIMARY
CAS
262438-43-7
Created by admin on Fri Dec 15 16:29:17 GMT 2023 , Edited by admin on Fri Dec 15 16:29:17 GMT 2023
PRIMARY
FDA UNII
XW0H5LE42K
Created by admin on Fri Dec 15 16:29:17 GMT 2023 , Edited by admin on Fri Dec 15 16:29:17 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY
A small peptide antagonist of integrin alpha5beta1 with potential antineoplastic activity. ATN-161 selectively binds to and blocks the receptor for integrin alpha5beta1, thereby preventing integrin alpha.5beta1 binding.
ACTIVE MOIETY
ATN-161 was well tolerated at all dose levels. Approximately, 1/3 of the patients in the study manifested prolonged stable disease. These findings suggest that ATN-161 should be investigated further as an antiangiogenic and antimetastatic cancer agent alone or with chemotherapy.